Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Pure Bioscience (PURE)

Pure Bioscience (PURE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0653 +0.0053 (+8.83%) 04/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0653 unch (unch) 12:49 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0564
Day High
0.0653
Open 0.0630
Previous Close 0.0600 0.0600
Volume 19,000 19,000
Avg Vol 44,500 44,500
Stochastic %K 21.09% 21.09%
Weighted Alpha -45.51 -45.51
5-Day Change +0.0033 (+5.32%) +0.0033 (+5.32%)
52-Week Range 0.0450 - 0.1640 0.0450 - 0.1640
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 7,830
  • Shares Outstanding, K 111,856
  • Annual Sales, $ 1,960 K
  • Annual Income, $ -3,350 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.27
  • Price/Sales 3.72
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on 03/17/25
  • Next Earnings Date 06/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0564 +15.78%
on 04/25/25
Period Open: 0.0884
0.0977 -33.16%
on 04/02/25
-0.0231 (-26.13%)
since 03/25/25
3-Month
0.0450 +45.11%
on 03/10/25
Period Open: 0.0715
0.0977 -33.16%
on 04/02/25
-0.0062 (-8.67%)
since 01/24/25
52-Week
0.0450 +45.11%
on 03/10/25
Period Open: 0.0700
0.1640 -60.18%
on 11/15/24
-0.0047 (-6.71%)
since 04/25/24

Most Recent Stories

More News
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal 2022 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0653 (+8.83%)
PURE Bioscience Reports Fiscal 2021 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0653 (+8.83%)

Business Summary

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including methicillin-resistant Staphylococcus aureus (MRSA), or staph infection. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its...

See More

Key Turning Points

3rd Resistance Point 0.0772
2nd Resistance Point 0.0712
1st Resistance Point 0.0683
Last Price 0.0653
1st Support Level 0.0594
2nd Support Level 0.0534
3rd Support Level 0.0505

See More

52-Week High 0.1640
Fibonacci 61.8% 0.1185
Fibonacci 50% 0.1045
Fibonacci 38.2% 0.0905
Last Price 0.0653
52-Week Low 0.0450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective